Looks like we are hammered with a 5% drop this morning with missed earnings. I guess we have to wait for more conferences to see how the products are doing before the street like us again. Wish we would be bought out!
What I can't understand is why insider Gould has sold all his shares. Made a lot of jack. But you would have thought he would keep some. Maybe he left the company. Anyone know?
MorningNotes® SPO Notes
DEAL PRICED Epizyme, Inc. SPO (EPZM:Nasdaq)
Wednesday 03/18/2015 8:21 AM ET - MorningNotes
6,000,000 shares @ $20.75, last sale $21.13. Up-sized from 4,750,000 shares. Managers: Leerink Swann, Cowen & Company, RBC Capital Markets
CHATTER Epizyme, Inc. SPO (EPZM:Nasdaq)
Tuesday 03/17/2015 2:30 PM ET - MorningNotes
4,750,000 shares @ $22.07 Managers: Leerink Swann, Cowen & Company, RBC Capital Markets We hear demand is strong and like the pull back today. We have increased our rating to reflect this.
thiswil crash under $15 investor not happy with deluting shares
Who ever bought asre already losing will lose more when it crash below $15 $15 ,investor will dump these share
No investor want to see deluting shares time to dump dump sell sell
Leerink and Cowen already purchased the shares at $19.505 which is at a discount to the public. As for EPZM, they raised the money they needed. In hindsight, this seems like it was a smart move.
On March 17, 2015, Epizyme, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Leerink Partners LLC and Cowen and Company, LLC, as representatives of the several underwriters (collectively, the "Underwriters"), relating to an underwritten public offering of 6,000,000 shares (the "Shares") of the Company's common stock, par value $0.0001 per share (the "Common Stock"). All of the Shares are being sold by the Company. The offering price to the public is $20.75 per share, and the Underwriters have agreed to purchase the Shares from the Company pursuant to the Underwriting Agreement at a price of $19.505 per share. Under the terms of the Underwriting Agreement, the Company granted the Underwriters an option, exercisable for 30 days, to purchase up to an additional 900,000 shares of Common Stock at the same price per share as the Shares.
That is a little over 20 percent more shares if everything goes through ,sell sell sell no investor like to see deluting shares
No investor will be happy with deluting shares that iswhythey dumping shares , i hope every investor dump dump thier shares to teach them a lesson for deluting share this crashingbelow $15 $15 $15 i hope all investor dump thierr shares in protest dump dump
Celgene already has a 12.5% stake in EPZM. Perhaps they just take them out here. That would be nice. Many options but with their nice cash cushion, I think EPZM controls their own destiny.